State Street’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.15M | Sell |
849,424
-51,930
| -6% | -$498K | ﹤0.01% | 2708 |
|
2025
Q1 | $5.65M | Sell |
901,354
-138,582
| -13% | -$869K | ﹤0.01% | 2827 |
|
2024
Q4 | $8.44M | Buy |
1,039,936
+117,148
| +13% | +$951K | ﹤0.01% | 2720 |
|
2024
Q3 | $16.7M | Buy |
922,788
+137,539
| +18% | +$2.49M | ﹤0.01% | 2320 |
|
2024
Q2 | $8.09M | Buy |
785,249
+68,048
| +9% | +$701K | ﹤0.01% | 2688 |
|
2024
Q1 | $7.62M | Buy |
717,201
+29,364
| +4% | +$312K | ﹤0.01% | 2734 |
|
2023
Q4 | $6.28M | Buy |
687,837
+20,241
| +3% | +$185K | ﹤0.01% | 2847 |
|
2023
Q3 | $6.92M | Buy |
667,596
+137,753
| +26% | +$1.43M | ﹤0.01% | 2766 |
|
2023
Q2 | $7.59M | Buy |
529,843
+66,100
| +14% | +$947K | ﹤0.01% | 2792 |
|
2023
Q1 | $3.31M | Buy |
463,743
+12,394
| +3% | +$88.5K | ﹤0.01% | 3144 |
|
2022
Q4 | $5.06M | Buy |
451,349
+5,854
| +1% | +$65.7K | ﹤0.01% | 3038 |
|
2022
Q3 | $4.94M | Buy |
445,495
+36,613
| +9% | +$406K | ﹤0.01% | 3067 |
|
2022
Q2 | $3.45M | Buy |
408,882
+43,838
| +12% | +$370K | ﹤0.01% | 3278 |
|
2022
Q1 | $4.97M | Buy |
365,044
+23,104
| +7% | +$314K | ﹤0.01% | 3183 |
|
2021
Q4 | $6.73M | Sell |
341,940
-12,824
| -4% | -$252K | ﹤0.01% | 3109 |
|
2021
Q3 | $11.4M | Buy |
354,764
+14,461
| +4% | +$464K | ﹤0.01% | 2811 |
|
2021
Q2 | $11.5M | Buy |
340,303
+123,105
| +57% | +$4.17M | ﹤0.01% | 2831 |
|
2021
Q1 | $8.16M | Buy |
217,198
+8,148
| +4% | +$306K | ﹤0.01% | 2834 |
|
2020
Q4 | $6.95M | Sell |
209,050
-5,257
| -2% | -$175K | ﹤0.01% | 2805 |
|
2020
Q3 | $7.86M | Buy |
214,307
+1,500
| +0.7% | +$55K | ﹤0.01% | 2568 |
|
2020
Q2 | $7M | Buy |
212,807
+25,499
| +14% | +$839K | ﹤0.01% | 2597 |
|
2020
Q1 | $4.84M | Buy |
187,308
+62,065
| +50% | +$1.6M | ﹤0.01% | 2644 |
|
2019
Q4 | $3.9M | Buy |
+125,243
| New | +$3.9M | ﹤0.01% | 2957 |
|